Synthetic molecular motor activates drug delivery from polymersomes

The design of stimuli-responsive systems in nanomedicine arises from the challenges associated with the unsolved needs of current molecular drug delivery. Here, we present a delivery system with high spatiotemporal control and tunable release profiles. The design is based on the combination of an hy...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 2023-07, Vol.120 (27), p.e2301279120-e2301279120
Main Authors: Guinart, Ainoa, Korpidou, Maria, Doellerer, Daniel, Pacella, Gianni, Stuart, Marc C A, Dinu, Ionel Adrian, Portale, Giuseppe, Palivan, Cornelia, Feringa, Ben L
Format: Article
Language:English
Subjects:
Biological Sciences
Block copolymers
Cell Line
Cell viability
Drug Carriers - chemistry
Drug delivery
Drug Delivery Systems
Drug development
Fluorescent Dyes
Fluorescent indicators
Hydrophobic and Hydrophilic Interactions
Hydrophobicity
Low concentrations
Lung cancer
Molecular machines
Molecular motors
Nanotechnology
Physical Sciences
Polymers - chemistry
Self-assembly
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The design of stimuli-responsive systems in nanomedicine arises from the challenges associated with the unsolved needs of current molecular drug delivery. Here, we present a delivery system with high spatiotemporal control and tunable release profiles. The design is based on the combination of an hydrophobic synthetic molecular rotary motor and a PDMS- -PMOXA diblock copolymer to create a responsive self-assembled system. The successful incorporation and selective activation by low-power visible light (λ = 430 nm, 6.9 mW) allowed to trigger the delivery of a fluorescent dye with high efficiencies (up to 75%). Moreover, we proved the ability to turn on and off the responsive behavior on demand over sequential cycles. Low concentrations of photoresponsive units (down to 1 mol% of molecular motor) are shown to effectively promote release. Our system was also tested under relevant physiological conditions using a lung cancer cell line and the encapsulation of an Food and Drug Administration (FDA)-approved drug. Similar levels of cell viability are observed compared to the free given drug showing the potential of our platform to deliver functional drugs on request with high efficiency. This work provides an important step for the application of synthetic molecular machines in the next generation of smart delivery systems.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2301279120